Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MXCT compared with IQV: revenue, margins and what each company keeps, and the suppliers and customers both name
MXCT
Maxcyte, Inc.
Change
Mkt cap
Revenue
Revenue
IQV
Iqvia Holdings Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MXCT
Maxcyte, Inc.
vs
IQV
Iqvia Holdings Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
MXCT
Maxcyte, Inc.
Change
1.43
▼
−1.67%
Mkt cap
$149.6M
Revenue
$7M
Q2 FY26
Revenue
$33M
FY25
IQV
Iqvia Holdings Inc.
Change
261.92
▲
+1.35%
Regular session
Nov 3 '26
Mkt cap
$42.6B
Revenue
$4.4B
Q3 FY26
Revenue
$16.3B
FY25
vs
Compare
Regular session
Nov 3 '26
MXCT
Maxcyte, Inc.
vs
IQV
Iqvia Holdings Inc.
1.43
▼
−1.67%
Price
261.92
▲
+1.35%
$149.6M
Mkt cap
$42.6B
Q2 FY26
$7M
Revenue
$4.4B
Q3 FY26
FY25
$33M
Revenue
$16.3B
FY25
Change
Change
MXCT
1.43
▼
−1.67%
vs
IQV
261.92
▲
+1.35%
Regular session
Nov 3 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
MXCT: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MXCT
5
TGTX
TG Therapeutics
customer
DTIL
Precision BioSciences
customer
—
SeQure Dx
unlisted
supplier
—
Imugene (USA)
unlisted
customer
1 more · MXCT chain
›
Shared
0
No shared counterparties.
Only IQV
1
VSTM
Verastem
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MXCT, solid
IQV, dashed